PUBLIC MODEL SCORE

LLY Eli Lilly and Company

Pharmaceuticals

$1443.50+16.22 (1.14%)
Open

$1429.91

High

$1449.64

Low

$1419.77

Prev close

$1427.28

Sell(82%)Fundamentals B (69/100)Low Risk

GLP-1 franchise with supply catching demand. Pipeline (oral incretins) is the duration question. Not an AI trade.

Supply rampOral pipelineCategory growth

Fundamental snapshot live vendor metrics

P/E

65.5x

Revenue growth

45.5%

Op. margin

40.3%

ROE

83.7%

Open AI screenerMarket heatmap

Charts and a small watchlist — free

This page is the public score. A free account saves LLY and unlocks candles.

Create free account

Premium workflow

This page scores one ticker. Premium runs a book.

Co-Pilot on holdings you save, Fund+TA ranked shortlist, Alpha Engine, Rotation Monitor, Thesis, Simulator, Guardian, and the morning briefing. The public score cannot see your account.

Start 7-day trial · $14/mo after

Educational model output only. Not a recommendation to buy or sell Eli Lilly and Company. See Terms.